Alhamadani, Isra, Mohammed Alzyadi, and Mohauman Majeed. “Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 Prognostic Value”. Archives of Breast Cancer 13, no. 2 (April 22, 2026): 154–165. Accessed May 30, 2026. https://www.archbreastcancer.com/index.php/abc/article/view/1224.